Literature DB >> 25361990

Phase I trials in oncology: a new era has started.

S Postel-Vinay1, J-C Soria2.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25361990     DOI： 10.1093/annonc/mdu513

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

Review 1.  Phase I trials as valid therapeutic options for patients with cancer.

Authors:  Jacob J Adashek; Patricia M LoRusso; David S Hong; Razelle Kurzrock
Journal:  Nat Rev Clin Oncol       Date:  2019-09-02       Impact factor: 66.675

2.  Patient-reported outcome measures in a pharmacokinetic study with sunitinib, a prospective cohort study.

Authors:  J J Koldenhof; N A G Lankheet; N Steeghs; S C C M Teunissen; P O Witteveen
Journal:  Support Care Cancer       Date:  2018-02-21       Impact factor: 3.603

3.  Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trials.

Authors:  Andrew W Hahn; Omar Alhalabi; Pavlos Msaouel; Funda Meric-Bernstam; Aung Naing; Eric Jonasch; Sarina Piha-Paul; David Hong; Shubham Pant; Timothy Yap; Erick Campbell; Hung Le; Nizar M Tannir; Jason Roszik; Vivek Subbiah
Journal:  ESMO Open       Date:  2020-11

Review 4.  Immuno-oncology trends: preclinical models, biomarkers, and clinical development.

Authors:  Maryland Rosenfeld Franklin; Suso Platero; Kamal S Saini; Giuseppe Curigliano; Steven Anderson
Journal:  J Immunother Cancer       Date:  2022-01       Impact factor: 13.751

Review 5.  Antibody-drug conjugates: beyond current approvals and potential future strategies.

Authors:  Siddharth Menon; Sagun Parakh; Andrew M Scott; Hui K Gan
Journal:  Explor Target Antitumor Ther       Date:  2022-04-28

6.  Recruitment, outcomes, and toxicity trends in phase I oncology trials: Six-year experience in a large institution.

Authors:  Siddharth Menon; Amy Davies; Sophia Frentzas; Cheryl-Ann Hawkins; Eva Segelov; Daphne Day; Ben Markman
Journal:  Cancer Rep (Hoboken)       Date:  2021-07-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.